Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222841
Title: Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy
Author: Schiava, Marianela
Parkhurst, Yolande
Henderson, Matthew
Polvikoski, Tuomo
Valtcheva, Manouela V.
Nishino, Ichizo
Inoue, Michio
Nishimori, Yukako
Saito, Yoshihiko
Stojkovic, Tanya
Villar Quiles, Rocio N.
Beatriz Romero, Norma
Evangelista, Teresinha
Malfatti, Edoardo
Souvannanorath, Sarah
Pegoraro, Elena
Riguzzi, Pietro
Monforte, Mauro
Bortolani, Sara
Torchia, Eleonora
Sabatelli, Mario
Tasca, Giorgio
Straub, Volker
Marini Bettolo, Chiara
Guglieri, Michela
Cetin, Hakan
Gelpi, Ellen
Klotz, Sigrid
De Bleecker, Jan L.
Alonso Jiménez, Alicia
Baets, Jonathan
De Ridder, Willem
De Jonghe, Peter
Claeys, Kristl G.
Thal, Dietmar Rudolf
Bevilacqua, Jorge A.
Luo, Sushan
Zhu, Wenhua
Lin, Jie
Papadimas, George
Papadopoulos, Constantinos
Zamba-Papanicolaou, Eleni
Xirou, Sophia
Pal, Endre
Rodolico, Carmelo
Kostera-Pruszczyk, Anna
Kierdaszuk, Biruta
Kaminska, Anna
Muelas, Nuria
Vilchez, Juan Jesús
Domínguez González, Cristina
Hernández Lain, Aurelio
Alonso Pérez, Jorge
Nedkova-Hristova, Velina
Aledo, Carlos
Oldfors, Anders
Badrising, Umesh A.
Kushlaf, Hani
Lloyd, Thomas E.
Ikenaga, Chiseko
Alfano, Lindsay N.
Quinn, Colin C.
Walk, David
Vorgerd, Matthias
Weihl, Conrad
Olivé i Plana, Montserrat
Díaz Manera, Jordi
VCP International Study Group
Keywords: Malalties neuromusculars
Paraproteïnèmia
Neuromuscular diseases
Paraproteinemia
Issue Date: 16-Jul-2025
Publisher: Ovid Technologies (Wolters Kluwer Health)
Abstract: Background and Objectives Valosin Containing Protein-associated multisystem proteinopathy (VCP-MSP) is a progressive, autosomal dominant disorder caused by pathogenic variants in the VCP gene, resulting in a heterogeneous clinical presentation. Muscle biopsy findings are characteristic but not pathognomonic. This study aimed to comprehensively analyse VCP-related myopathology and explore correlations with clinical phenotypes, genetic variants, and disease progression. Methods Muscle biopsy images and data were collected retrospectively from adults (>= 18 years) with pathogenic or likely pathogenic VCP variants enrolled in the VCP Multicentre International Study. Biopsy data were standardized using the Common Data Elements for Muscle Biopsy Reporting. Variations in biopsy findings were analysed by biopsy site, time from disease onset, the four most common VCP variants, and clinical phenotypes. Result A total of 112 muscle biopsies were included. Most individuals were male (66.0%). The mean age at biopsy was 53.3 years (SD 10.0), with a mean disease duration of 6.5 years (SD 4.5). The most frequent VCP variant was c.464G>A (p.Arg155His) (18.8%). The top clinical phenotypes were isolated myopathy (37.5%), myopathy with Paget disease of bone (17.9%), and myopathy with motor neuron involvement (13.4%). The vastus lateralis was the most common biopsy site (34.8%), and 91% were open biopsies. Histopathologic findings included atrophic fibres (87.5%), rimmed vacuoles (72.3%), endomysial fibrosis (58.0%), and protein aggregates (51.8%), primarily p62 (60.3%) and VCP (36.2%). Degeneration niches with fibrofatty replacement and atrophic fibres were seen in 33.3% of biopsies without frequency differences by clinical phenotypes. There were no differences in biopsy findings among the 4 most common VCP gene variants, except for the absence of degeneration niches in muscle biopsies of 12 patients with c.277C>T (p.Arg93Cys). MRI data from 30 patients showed fat pockets corresponding to these niches and STIR hyperintensity correlated with inflammatory infiltrates in 42.9%. Concordance between clinical phenotype, biopsy, and neurophysiology was observed in only 49.4% of cases, indicating significant heterogeneity. Discussion VCP-MSP muscle biopsies consistently show myopathic or mixed patterns with rimmed vacuoles and p62/VCP-positive inclusions, regardless of clinical phenotype, age, or progression. Some lack vacuoles, challenging diagnosis. Discrepancies between clinical, neurophysiology, and biopsy findings should prompt consideration of VCP-MSP to improve detection and management.
Note: Reproducció del document publicat a: https://doi.org/10.1212/NXG.0000000000200265
It is part of: Neurology Genetics, 2025, vol. 11, num. 4
URI: https://hdl.handle.net/2445/222841
Related resource: https://doi.org/10.1212/NXG.0000000000200265
ISSN: 2376-7839
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))



This item is licensed under a Creative Commons License Creative Commons